A carregar...
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
Mammalian target of rapamycin (mTOR) is a master regulator of cell growth and metabolism, which is activated in response to intra- and extracellular signals, including nutrients, growth factors, and cellular energy levels. The frequent dysregulation of mTOR signaling in cancer makes it an attractive...
Na minha lista:
| Publicado no: | Int J Nanomedicine |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7418174/ https://ncbi.nlm.nih.gov/pubmed/32821100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S254574 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|